VOR — Vor Biopharma Inc. catalysts
Next verified catalyst
2027-03-01 — A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-03 (month) in 4mo
ESTIMATED |
READOUT
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPST
Phase 3 · Generalized Myasthenia Gravis |
VOR Vor Biopharma Inc. | Telitacicept |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-01
Sponsor-projected date — can change
|